Overview A Clinical Study to Evaluate the Long-term Safety of HRS-1893 in Hypertrophic Cardiomyopathy Status: RECRUITING Trial end date: 2027-12-01 Target enrollment: Participant gender: Summary This study mainly evaluates the long-term safety of HRS-1893 in subjects with hypertrophic cardiomyopathy.Phase: PHASE2 Details Lead Sponsor: Shandong Suncadia Medicine Co., Ltd.